Humanigen seeks EUA from USFDA for Lenzilumab to treat COVID-19
This EUA application follows positive results from the LIVE-AIR Phase 3 clinical trial evaluating the ability of lenzilumab to…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Humanigen
Humanigen, EVERSANA to partner for launch, commercialisation of Lenzilumab for COVID-19 treatment
Lenzilumab, a monoclonal antibody, is designed to prevent and treat cytokine storm, a complication considered to be a leading…
Humanigen announces positive interim data of Lenzilumab in hospitalised COVID-19 patients
The company intends to file for EUA in the first quarter of 2021 either following interim data at 75 per cent or at study…